Ming Li

Member, Memorial Sloan Kettering Cancer Center
Views expressed are not affiliated with my employer.

[Ming Li @MingLiLab]

@KarunaMDPhD @Nature Beautiful work! Congratulations, Karuna!

[Ming Li @MingLiLab]

Glad to share our review article from talented @LiangliangJi and coauthors @NatRevImmunol on the fascinating topic of monocytes and macrophages in cancer. Understanding their contextual roles across primary and metastatic tumors shall guild their therapeutic targeting.

[Ming Li @MingLiLab]

High rate ATP production accounts for the Warburg Effect, perhaps in support of energy-demanding processes such as PI3K signaling in effector T cells

[Denis Titov @Denis_V_Titov]

Excited to share our new paper led by @mattabolite in collaboration with Saharon Rosset showing that the Warburg Effect is the result of faster ATP production by glycolysis than respiration. A 🧵... 1/n https://t.co/m32QAaK4i0

[Ming Li @MingLiLab]

Congrats to Andrea ⁦@SchietingerLab⁩ for the very well deserved ⁦@CancerResearch⁩ Frederick W. Alt Award! Brilliant science for cancer cure!!

[Ming Li @MingLiLab]

@RongFan8 Congrats, Rong, for the beautiful story!

[Cell @CellCellPress]

Now online! Dynamic allostery drives autocrine and paracrine TGF-β signaling https://t.co/rFCao4JLgK

[Ming Li @MingLiLab]

@SantoshVardhana @theNCI @nih_nhlbi @chaudhuj Congrats!

[Ming Li @MingLiLab]

@XinboYang777 Thanks, Xinbo!

[Ming Li @MingLiLab]

@Zihai Happy 4th, Zihai!

[Ming Li @MingLiLab]

Glad to share our review article @AnnualReviews on tissue-resident innate and adaptive lymphocytes in cancer. Defining their identities and sensing mechanisms shall guide targeting such prewired and priming-dependent defense responses for cancer therapies. https://t.co/pg5DmGsLcN

[Ming Li @MingLiLab]

@RuthFranklinLab @ImmunologyAAI @rodz_patricia Congrats! I heard that your talk was very well received.

[Ming Li @MingLiLab]

@ChangyuZhu1 @TobiWalther @BobFarese @MaraShermanLab @RichardKoche @mason_lab Congrats, Changyu!

[Cancer Research Institute @CancerResearch]

28 cancers are now treatable with immunotherapy, thanks to the work of the Cancer Research Institute. Explore our Impact Report, and discover how CRI is transforming the lives of cancer patients on a global scale: https://t.co/AD6s5fn0F8 #CancerResearch #Immunotherapy

[Ming Li @MingLiLab]

@dorina_avram Thanks, Dorina!

[Ming Li @MingLiLab]

Thanks to @MSKCancerCenter for covering it!

[Memorial Sloan Kettering Cancer Center @MSKCancerCenter]

MSK's Dr. Ming Li (@MingLiLab) discusses how his lab is working to harness the power of the immune system against #cancer — including a new paper just out in @ImmunityCP. https://t.co/ip85BZJJSh

[Ming Li @MingLiLab]

@XuZhouLab Thanks, Xu! This is another example of heterocellular competition in addition to competition between TAMs and cancer cells in the Myc-PyMT model

[Ming Li @MingLiLab]

Reprogram tumor-associated macrophages to outcompete endothelial progenitor cells and suppress tumor neoangiogenesis. Excited to share our new study @ImmunityCP by brilliant @miahdo1 , Wei Shi, and @CancerResearch fellow @LiangliangJi and collaborators!

[Ming Li @MingLiLab]

@wenzhang1120 Thanks, Wen!

[Ming Li @MingLiLab]

@GitlinLab_MSK Thanks, Alex!

[Ming Li @MingLiLab]

@SunLab_Official Thanks, Joe!

[Ming Li @MingLiLab]

@JiefuBiol Thanks, Jiefu!